Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent in a Cancer Pain Model

NCT00101621 is registered in ClinicalTrials.gov with MetaPhore Pharmaceuticals as lead sponsor.

NCT NCT00101621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00101621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent in a Cancer Pain Model
Lead sponsor
MetaPhore Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2004
Completion date
August 31, 2005
Enrollment
24
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain